QQ客服 官方微博 反馈留言

浏览/检索结果: 共20条，第1-10条 帮助 限定条件 发表日期：2018    专题：中国医学科学院 北京协和医学院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Small-molecule compounds targeting the STAT3 DNA-binding domain suppress survival of cisplatin-resistant human ovarian cancer cells by inducing apoptosis 期刊论文 2018, 卷号: 157, 页码: 887-897 作者:  Huang, Wei;  Liu, Yuan;  Wang, Jun;  Yuan, Xia;  Jin, Hong-Wei 收藏  |  浏览/下载：5/0  |  提交时间：2020/01/03 Signal transducer and activator of transcription 3 (STAT3)  DNA binding domain (DBD)  Similarity screening  Microscale thermophoresis  Cisplatin resistance   Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials 期刊论文 2018, 卷号: 19, 期号: 10, 页码: 1338-1350 作者:  Fang, Wenfeng;  Yang, Yunpeng;  Ma, Yuxiang;  Hong, Shaodong;  Lin, Lizhu 收藏  |  浏览/下载：7/0  |  提交时间：2020/01/03 Clinical efficacy of bevacizumab combined with gemcitabine and cisplatin combination chemotherapy in the treatment of advanced non-small cell lung cancer 期刊论文 2018, 卷号: 23, 期号: 5, 页码: 1402-1406 作者:  Duan, Jianchun;  Yang, Zhenhua;  Liu, Dingyuan;  Zhang, Zhen;  Shi, Yunfei 收藏  |  浏览/下载：2/0  |  提交时间：2020/01/03 advanced non-small cell lung cancer  bevacizumab  survival rate  clinical effect  GP chemotherapy   Effects of cisplatin on surgically induced endometriosis in a rat model 期刊论文 2018, 卷号: 16, 期号: 4, 页码: 5282-5290 作者:  Li Zhanfei;  Liu Huibing;  Lang Jinghe;  Zhang Guorui;  He Zhengxing 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03 chemotherapy  cisplatin  endometriosis  rat model  treatment   Efficacy and safety of rh-endostatin (Endostar) combined with pemetrexed/cisplatin followed by rh-endostatin plus pemetrexed maintenance in non-small cell lung cancer: A retrospective comparison with standard chemotherapy 期刊论文 2018, 卷号: 9, 期号: 11, 页码: 1354-1360 作者:  Zhou, Shengyu;  Zuo, Lijie;  He, Xiaohui;  Pi, Jinping;  Jin, Jun 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03 Anti-angiogenesis  maintenance  non-small cell lung cancer  rh-endostatin   Phase 2 Study of First-line Intensity Modulated Radiation Therapy Followed by Gemcitabine, Dexamethasone, and Cisplatin for High-Risk, Early Stage Extranodal Nasal-Type NK/T-Cell Lymphoma: The GREEN Study 期刊论文 2018, 卷号: 102, 期号: 1, 页码: 61-70 作者:  Qi, Fei;  Wang, Wei-Hu;  He, Xiao-Hui;  Chen, Bo;  Gui, Lin 收藏  |  浏览/下载：5/0  |  提交时间：2020/01/03 Preparation and Optimization Lipid Nanocapsules to Enhance the Antitumor Efficacy of Cisplatin in Hepatocellular Carcinoma HepG2 Cells 期刊论文 2018, 卷号: 19, 期号: 5, 页码: 2048-2057 作者:  Zhai, Qingqing;  Li, Hailong;  Song, Yanlin;  Wu, Ruijiao;  Tang, Chuanfang 收藏  |  浏览/下载：7/0  |  提交时间：2020/01/03 lipid nanocapsule  hepatocellular carcinoma  cisplatin  solutol HS 15  cremophor EL   RNF138 confers cisplatin resistance in gastric cancer cells via activating Chk1 signaling pathway 期刊论文 2018, 卷号: 19, 期号: 12, 页码: 1128-1138 作者:  Lu, Yalan;  Han, Deqiang;  Liu, Wenjie;  Huang, Rong;  Ou, Jinhuan 收藏  |  浏览/下载：16/0  |  提交时间：2020/01/03 RNF138  cisplatin resistance  gastric cancer  Chk1  viability  apoptosis  cell cycle   DUOXA1-mediated ROS production promotes cisplatin resistance by activating ATR-Chk1 pathway in ovarian cancer 期刊论文 2018, 卷号: 428, 页码: 104-116 作者:  Meng, Yunxiao;  Chen, Chi-Wei;  Yung, Mingo M. H.;  Sun, Wei;  Sun, Jing 收藏  |  浏览/下载：5/0  |  提交时间：2020/01/03 ROS  High throughput screen  Cisplatin resistance  Ovarian cancer  DUOXA1  ATR-Chk1   Nanoparticle co-delivery of wortmannin and cisplatin synergistically enhances chemoradiotherapy and reverses platinum resistance in ovarian cancer models 期刊论文 2018, 卷号: 169, 页码: 1-10 作者:  Zhang, Maofan;  Hagan, C. Tilden;  Min, Yuangzeng;  Foley, Hayley;  Tian, Xi 收藏  |  浏览/下载：1/0  |  提交时间：2020/01/03 Nanoparticle  Combination therapy  Platinum resistance  Treatment synergy  Ovarian cancer